Shengnan Hao

948 total citations
38 papers, 593 citations indexed

About

Shengnan Hao is a scholar working on Artificial Intelligence, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shengnan Hao has authored 38 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Artificial Intelligence, 12 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shengnan Hao's work include AI in cancer detection (8 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Shengnan Hao is often cited by papers focused on AI in cancer detection (8 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Shengnan Hao collaborates with scholars based in China, Ireland and Bulgaria. Shengnan Hao's co-authors include Haiting Mao, Иван Ганчев, Zhanlin Ji, Xi Chen, Qianqian Shao, Zhonghua Zhao, Baosheng Li, Ying He, Zicheng Zhang and Wenjuan Gao and has published in prestigious journals such as Nature Communications, PLoS ONE and IEEE Access.

In The Last Decade

Shengnan Hao

33 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengnan Hao China 14 202 200 102 75 65 38 593
Aleksandra Popović United States 16 181 0.9× 317 1.6× 70 0.7× 88 1.2× 129 2.0× 40 1.0k
Changgong Zhang China 17 126 0.6× 291 1.5× 46 0.5× 204 2.7× 71 1.1× 93 861
Shuoyu Xu China 18 80 0.4× 293 1.5× 189 1.9× 158 2.1× 182 2.8× 67 1.2k
Mengmeng Zhao China 18 127 0.6× 91 0.5× 155 1.5× 80 1.1× 322 5.0× 70 948
Fan Xu China 19 44 0.2× 181 0.9× 44 0.4× 78 1.0× 192 3.0× 46 771
Eunmi Lee South Korea 12 221 1.1× 182 0.9× 33 0.3× 17 0.2× 44 0.7× 42 759
Yanfeng Zhao China 18 28 0.1× 72 0.4× 408 4.0× 118 1.6× 231 3.6× 71 836
Yong Luo China 16 22 0.1× 63 0.3× 144 1.4× 63 0.8× 75 1.2× 54 651

Countries citing papers authored by Shengnan Hao

Since Specialization
Citations

This map shows the geographic impact of Shengnan Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Hao more than expected).

Fields of papers citing papers by Shengnan Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Hao. The network helps show where Shengnan Hao may publish in the future.

Co-authorship network of co-authors of Shengnan Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Hao. A scholar is included among the top collaborators of Shengnan Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Hao. Shengnan Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Shengnan, et al.. (2025). Machine learning-guided prediction of polymeric membrane performance in forward osmosis. Separation and Purification Technology. 379. 135037–135037. 1 indexed citations
2.
3.
4.
Hao, Shengnan, et al.. (2025). BCS_YOLO: Research on Corn Leaf Disease and Pest Detection Based on YOLOv11n. Applied Sciences. 15(15). 8231–8231.
5.
Hao, Shengnan, et al.. (2024). ST-Double-Net: A Two-Stage Breast Tumor Classification Model Based on Swin Transformer and Weakly Supervised Target Localization. IEEE Access. 12. 117921–117933. 5 indexed citations
6.
Ai, Dashan, Shengnan Hao, Wenbin Shen, et al.. (2024). Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial. EClinicalMedicine. 69. 102471–102471. 16 indexed citations
7.
Hao, Shengnan, et al.. (2024). DTONet a Lightweight Model for Melanoma Segmentation. Bioengineering. 11(4). 390–390. 2 indexed citations
8.
9.
Ji, Zhanlin, et al.. (2024). AFCF-Net: A novel U-Net based asymmetric feature calibration and fusion network for skin lesion image segmentation. PLoS ONE. 19(11). e0314000–e0314000. 2 indexed citations
10.
Hao, Shengnan, et al.. (2024). YOLO-CXR: A Novel Detection Network for Locating Multiple Small Lesions in Chest X-Ray Images. IEEE Access. 12. 156003–156019. 21 indexed citations
11.
Hao, Shengnan, et al.. (2023). GSCEU-Net: An End-to-End Lightweight Skin Lesion Segmentation Model with Feature Fusion Based on U-Net Enhancements. Information. 14(9). 486–486. 3 indexed citations
12.
13.
Li, Fangfang, Dashan Ai, Yun Chen, et al.. (2023). Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials. The Oncologist. 28(8). e645–e652. 5 indexed citations
14.
Liu, Qi, Junqiang Chen, Lin Yu, et al.. (2023). Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial. ˜The œLancet. Gastroenterology & hepatology. 9(1). 45–55. 28 indexed citations
15.
Hao, Shengnan, et al.. (2021). Novel SDDM Rating Prediction Models for Recommendation Systems. IEEE Access. 9. 101197–101206. 10 indexed citations
16.
Liu, Jia, Shengnan Hao, Xi Chen, et al.. (2019). Human placental trophoblast cells contribute to maternal–fetal tolerance through expressing IL-35 and mediating iTR35 conversion. Nature Communications. 10(1). 4601–4601. 47 indexed citations
17.
Liu, Jia, Shengnan Hao, Hui Zhao, et al.. (2019). Human chorionic gonadotropin and IL-35 contribute to the maintenance of peripheral immune tolerance during pregnancy through mediating the generation of IL-10+ or IL-35+ Breg cells. Experimental Cell Research. 383(2). 111513–111513. 15 indexed citations
18.
Chen, Xi, Shengnan Hao, Zhonghua Zhao, et al.. (2018). Interleukin 35: Inhibitory regulator in monocyte-derived dendritic cell maturation and activation. Cytokine. 108. 43–52. 29 indexed citations
19.
Zhao, Zhonghua, Xi Chen, Shengnan Hao, et al.. (2016). Increased interleukin-35 expression in tumor-infiltrating lymphocytes correlates with poor prognosis in patients with breast cancer. Cytokine. 89. 76–81. 34 indexed citations
20.
Hao, Shengnan, et al.. (2015). Improved SVM method for internet traffic classification based on feature weight learning. 102–106. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandra Popović Breakdown of academic impact, for papers by Changgong Zhang Breakdown of academic impact, for papers by Shuoyu Xu Breakdown of academic impact, for papers by Mengmeng Zhao Breakdown of academic impact, for papers by Fan Xu Breakdown of academic impact, for papers by Eunmi Lee Breakdown of academic impact, for papers by Yanfeng Zhao Breakdown of academic impact, for papers by Yong Luo
Rankless by CCL
2026